Shuzhen Liang

机构：The First People's Hospital of Shunde

发表论文 36 篇 · 总被引 1003 次 · h-index 20

代表论文

• Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients (2020 · Journal of Clinical Investigation · 被引 137)
• Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients (2020 · Signal Transduction and Targeted Therapy · 被引 93)
• Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome (2018 · Cellular Physiology and Biochemistry · 被引 68)
• Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment (2017 · Journal of Cancer Research and Clinical Oncology · 被引 57)
• Pleiotrophin ameliorates age-induced adult hippocampal neurogenesis decline and cognitive dysfunction (2023 · Cell Reports · 被引 47)
• Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancer (2017 · Molecular Immunology · 被引 41)